Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vancomycin in 1991: current status and perspectives].

A Casetta1, E Bingen, N Lambert-Zechovsky

  • 1Laboratoire de Bactériologie, Hôpital Robert Debré, Paris, France.

Pathologie-Biologie
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.

The Journal of hospital infection·2019
Same author

Five-Day Spiramycin vs Seven-Day Penicillin V in the Treatment of Streptococcal Tonsillitis in Children.

Clinical drug investigation·2016
Same author

[Epidemiology of Streptococcus pyogenes invasive diseases in France (2007-2011)].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

[Epidemiology of invasive group A streptococcal infections in developed countries : the Canadian experience with necrotizing fasciitis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
Same author

Foodborne transmission of sorbitol-fermenting Escherichia coli O157:[H7] via ground beef: an outbreak in northern France, 2011.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Vancomycin, a glycopeptide antibiotic, inhibits Gram-positive bacterial growth by blocking peptidoglycan synthesis. It is crucial for treating resistant infections like MRSA and endocarditis, with rare resistance development.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Context:

  • Vancomycin is a critical glycopeptide antibiotic.
  • It exhibits narrow-spectrum activity, primarily against Gram-positive bacteria.
  • Bacterial resistance to vancomycin is infrequent due to its complex mechanisms of action.

Purpose:

  • To elucidate the mechanism of action of vancomycin.
  • To highlight its clinical applications and pharmacokinetic considerations.
  • To underscore its importance in managing challenging Gram-positive infections.

Summary:

  • Vancomycin functions by inhibiting bacterial peptidoglycan synthesis.
  • It achieves this by forming hydrogen bonds with the UDP-N-acetylmuramyl pentapeptide precursor.
  • In renal insufficiency, vancomycin clearance decreases, prolonging its elimination half-life.

Related Experiment Videos

Impact:

  • Vancomycin is the preferred treatment for methicillin-resistant Staphylococcus infections.
  • It is also a primary therapy for Gram-positive endocarditis.
  • It serves as an alternative for penicillin-allergic patients requiring treatment or prophylaxis for Gram-positive infections.